Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 28841 - 28860 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (G04BE08) tadalafil (adm: O) | Tadalafil (WGR) 10 mg tablet, 4 | Tablet 10 mg, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (G04BE08) tadalafil (adm: O) | Tadalafil (WGR) 20 mg tablet, 4 | Tablet 20 mg, 4 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (G04CA01) alfuzosin (adm: O) | Xatral SR 10 mg modified release tablet, 30 | Tablet 10 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | sanofi-aventisAustraliaPtyLtd |
| Australia | (G04CA01) alfuzosin (adm: O) | Xatral SR 10 mg modified release tablet, 30 | Tablet 10 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | sanofi-aventisAustraliaPtyLtd |
| Australia | (G04CA02) tamsulosin (adm: O) | Tamsulosin SR (WGR) 400 microgram modified release tablet, 30 | Tablet 400 micrograms (prolonged release), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (G04CA02) tamsulosin (adm: O) | Tamsulosin SR (WGR) 400 microgram modified release tablet, 30 | Tablet 400 micrograms (prolonged release), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (J01DD04) ceftriaxone (adm: P) | Ceftriaxone (Viatris) 1 g powder for injection, 10 vials | Powder for injection 1 g (as sodium), 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DD04) ceftriaxone (adm: P) | Ceftriaxone (Viatris) 1 g powder for injection, 10 vials | Powder for injection 1 g (as sodium), 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DD04) ceftriaxone (adm: P) | Ceftriaxone (Viatris) 2 g powder for injection, 10 vials | Powder for injection 2 g (as sodium), 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01DD04) ceftriaxone (adm: P) | Ceftriaxone (Viatris) 2 g powder for injection, 10 vials | Powder for injection 2 g (as sodium), 10 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (J01FA10) azithromycin (adm: O) | Azithromycin (Precision Dose, USA) 500 mg tablet, 3 | Tablet 500 mg (as dihydrate) (S19A), 3 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ReachPharmaceuticalsPtyLtd |
| Australia | (J01FA10) azithromycin (adm: O) | Azithromycin (Precision Dose, USA) 500 mg tablet, 3 | Tablet 500 mg (as dihydrate) (S19A), 3 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ReachPharmaceuticalsPtyLtd |
| Australia | (J01FA10) azithromycin (adm: O) | Azithromycin (WGR) 500 mg tablet, 3 | Tablet 500 mg (as dihydrate), 3 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (L01EF02) ribociclib (adm: O) | Kisqali 200 mg tablet, 21 | Tablet 200 mg, 21 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EF02) ribociclib (adm: O) | Kisqali 200 mg tablet, 21 | Tablet 200 mg, 21 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EF02) ribociclib (adm: O) | Kisqali 200 mg tablet, 42 | Tablet 200 mg, 42 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EF02) ribociclib (adm: O) | Kisqali 200 mg tablet, 42 | Tablet 200 mg, 42 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EF02) ribociclib (adm: O) | Kisqali 200 mg tablet, 63 | Tablet 200 mg, 63 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
Pages
